Chambers USA recognized the firm as a “powerhouse in the capital markets space.”
Chad Jennings is an associate in the Washington, D.C. office of Latham & Watkins and a member of the Healthcare & Life Sciences Practice. He focuses his practice on regulatory matters involving the Food and Drug Administration (FDA) and transactional matters involving the life sciences industry.
In particular, Mr. Jennings' practice is focused on transactional and regulatory matters involving the medical device, biotechnology, food, dietary supplement and cosmetic industries. Mr. Jennings has advised clients on diligence issues related to their most complex corporate transactions, including in understanding and assessing risks involved in all stages of the biotechnology product life cycle, such as:
- Pre-market product development and clinical and pre-clinical testing
- Product submissions
- Product promotion and labeling
- Compliance with manufacturing practice requirements
- Agency inspections and recalls
He represents leading banks and clients throughout the healthcare and life sciences industry including pharmaceutical and medical device manufacturers, and frequently advises on regulatory matters in connection with capital markets and M&A transactions involving FDA-regulated entities. Mr. Jennings regularly conducts diligence for major public and private financings, equity offerings and other transactions in the pharmaceutical, device and biotechnology sectors.
While in law school, Mr. Jennings was on the editorial board of the Virginia Sports and Entertainment Law Journal. Mr. Jennings also served as a judicial intern for Judge Norman K. Moon at the United States District Court for the Western District of Virginia. Before law school, Mr. Jennings performed consulting work for a liberal arts college developing undergraduate business curriculum and research materials relating to finance and international investment.